Reclusive Mankekar makes a splash with Solara stake
In the March quarter, Solara’s sales grew almost 50 per cent year-on-year to Rs 444 crore and net profit stood at Rs 56.6 crore, up 218 per cent. Synopsis The Mumbai-based reclusive investor held nearly 4 per cent stake in Sequent Scientific till March 2018 and about 2.07 per cent in Strides Pharma till September … Read more